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Abstract
Chondrocytes proliferate and mature into hypertrophic chondrocytes. Vascular invasion into
the cartilage occurs in the terminal hypertrophic chondrocyte layer, and terminal hypertro-
phic chondrocytes die by apoptosis or transdifferentiate into osteoblasts. Runx2 is essential
for osteoblast differentiation and chondrocyte maturation. Runx2-deficient mice are com-
posed of cartilaginous skeletons and lack the vascular invasion into the cartilage. However,
the requirement of Runx2 in the vascular invasion into the cartilage, mechanism of chondro-
cyte transdifferentiation to osteoblasts, and its significance in bone development remain to
be elucidated. To investigate these points, we generated Runx2fl/flCre mice, in which Runx2
was deleted in hypertrophic chondrocytes using Col10a1 Cre. Vascular invasion into the
cartilage was similarly observed in Runx2fl/fl and Runx2fl/flCre mice. Vegfa expression was
reduced in the terminal hypertrophic chondrocytes in Runx2fl/flCre mice, but Vegfa was
strongly expressed in osteoblasts in the bone collar, suggesting that Vegfa expression in
bone collar osteoblasts is sufficient for vascular invasion into the cartilage. The apoptosis of
terminal hypertrophic chondrocytes was increased and their transdifferentiation was inter-
rupted in Runx2fl/flCre mice, leading to lack of primary spongiosa and osteoblasts in the
region at E16.5. The osteoblasts appeared in this region at E17.5 in the absence of transdif-
ferentiation, and the number of osteoblasts and the formation of primary spongiosa, but not
secondary spongiosa, reached to levels similar those in Runx2fl/fl mice at birth. The bone
structure and volume and all bone histomophometric parameters were similar between
Runx2fl/fl and Runx2fl/flCre mice after 6 weeks of age. These findings indicate that Runx2
expression in terminal hypertrophic chondrocytes is not required for vascular invasion into
the cartilage, but is for their survival and transdifferentiation into osteoblasts, and that the
transdifferentiation is necessary for trabecular bone formation in embryonic and neonatal
stages, but not for acquiring normal bone structure and volume in young and adult mice.
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Author summary
Chondrocytes and osteoblasts are different lineage cells, which differentiate from mesen-
chymal stem cells through the regulation by different transcription factors. In endochon-
dral bone development, chondrocytes proliferate and mature to terminally differentiated
chondrocytes, and vascular invasion occurs in the layer of terminally differentiated chon-
drocytes. Terminally differentiated chondrocytes die by apoptosis or transdifferentiate
into osteoblasts, which contribute to bone formation. However, the molecular mechanism
and physiological significance of the transdifferentiation remain to be clarified. Runx2 is
an essential transcription factor for osteoblast differentiation and chondrocyte maturation
and has been considered to be required for vascular invasion into the cartilage. By deleting
Runx2 in differentiated chondrocytes, we elucidated that Runx2 is essential for the trans-
differentiation and is required for maintaining the survival of terminally differentiated
chondrocytes but not for vascular invasion into the cartilage. Furthermore, we clarified
that the transdifferentiation is required for trabecular bone formation in embryonic and
neonatal stages, but that it is dispensable for acquiring normal bone structure and volume
in young and adult mice probably due to the major contribution of osteoblasts originated
from perichondrium/periosteum.
Introduction
Vertebral skeletons are formed through intramembranous ossification or endochondral ossifi-
cation. In intramembranous ossification, bone is directly formed by osteoblasts. In endochon-
dral ossification, mesenchymal cells condense and differentiate into chondrocytes, and
cartilaginous skeletons are first formed by chondrocytes, which express Col2a1. Chondrocytes
proliferate and differentiate (maturate) to prehypertrophic chondrocytes, which express Ihh
and Pth1r, and then to hypertrophic chondrocytes, which express Col10a1. The hypertrophic
chondrocytes further differentiate (mature) into terminal hypertrophic chondrocytes, which
express Mmp13, Ibsp, and Spp1, the matrix is mineralized, blood vessels and osteoblast lineage
cells in the perichondrium invade the calcified cartilage, the matrix of cartilage is resorbed by
osteoclasts, and the cartilage is replaced with bone. During chondrocyte maturation, perichon-
drial cells differentiate into osteoblasts and form the bone collar through intramembranous
ossification [1, 2].
Runx2 is a transcription factor that belongs to Runx family, which is composed of Runx1,
Runx2, and Runx3 [3]. Runx2 is expressed in osteoblast progenitors and osteoblasts, and is
essential for the proliferation of osteoblast progenitors and their differentiation into osteoblasts
[4]. Runx2 is also expressed in chondrocytes, and its expression is upregulated in prehyper-
trophic chondrocytes and is maintained until terminal hypertrophic chondrocytes [2, 5].
Runx2-deficient (Runx2–/–) mice are composed of cartilaginous skeletons [6, 7]. Chondrocyte
maturation is inhibited in Runx2–/–mice and hypertrophic chondrocytes are absent in most of
the skeleton except the tibia, fibula, radius, and ulna, in which chondrocytes have fully
matured into terminal hypertrophic chondrocytes [2, 5]. However, vascular invasion into the
cartilage is absent in whole skeletons of Runx2–/–mice, probably due to the reduced Vegfa
expression in the terminal hypertrophic chondrocytes [8, 9]. Runx2 and Runx3 are essential
for chondrocyte maturation and Runx2 plays a major role in this process [10–13]. Runx2 upre-
gulates Ihh expression in prehypertrophic chondrocytes, and Ihh regulates chondrocyte prolif-
eration directly and regulates chondrocyte maturation through Pthlh [10, 14, 15]. Ihh is also
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required for Runx2 expression in perichondrial cells and their differentiation into osteoblasts
[15].
In the process of endochondral ossification, the terminal hypertrophic chondrocytes die by
apoptosis or transdifferentiate into osteoblasts [16–19]. Furthermore, it was recently reported
that the deletion of Ctnnb1 in hypertrophic chondrocytes increases bone resorption by
increasing the Rankl/Opg ratio and reduces the number of transdifferentiated osteoblasts from
chondrocytes, leading to a reduction in trabecular bone during the embryonic stage [20].
However, the molecular mechanism of the transdifferentiation of chondrocytes to osteoblasts
is poorly understood and its role in bone development remain to be clarified. Moreover, the
requirement of Runx2 expression in terminal hypertrophic chondrocytes for vascular invasion
into the cartilage needs to be investigated by hypertrophic chondrocyte-specific deletion of
Runx2. In this study, we generated Runx2 conditional knockout (Runx2fl/flCre) mice, in which
Runx2 was deleted in hypertrophic chondrocytes using Col10a1 promoter-Cre. We demon-
strated that Runx2 expression in terminal hypertrophic chondrocytes is essential for their
transdifferentiation to osteoblasts, but not for vascular invasion into the cartilage, and that the
transdifferentiation is transiently required for trabecular bone formation, but dispensable to
acquire normal bone mass in young and adult mice.
Results
Skeletal development was similar in Runx2fl/fl and Runx2fl/flCre mice at
E15.5, although apoptosis of terminal hypertrophic chondrocytes increased
in Runx2fl/flCre mice
Runx2fl/fl mice were generated as described in Materials and Methods and shown in S1 Fig.
Runx2fl/fl mice were mated with Col10a1-Cre transgenic mice [21] to generate Runx2fl/flCre
mice, in which Runx2 was specifically deleted in hypertrophic chondrocytes. On immunohis-
tochemical analysis using anti-Runx2 antibody, the number of Runx2-positive hypertrophic
chondrocytes in tibiae of Runx2fl/flCre mice was less than one twenty-fifth of that in wild-type
mice at E15.5 (Fig 1A–1C). Skeletal preparation revealed that mineralization was similar in
Runx2fl/fl and Runx2fl/flCre mice at E15.5 (Fig 1D and 1E). On histological analysis of femurs,
hematoxylin and eosin (H-E), von Kossa, alkaline phosphatase (ALP), and safranin O staining
confirmed the presence of chondrocyte hypertrophy, their terminal differentiation, vascular
invasion into the cartilage, and bone collar formation in both Runx2fl/fl and Runx2fl/flCre mice
at similar levels (Fig 1F–1M). However, the apoptosis of terminal hypertrophic chondrocytes
was increased in Runx2fl/flCre mice compared with that in Runx2fl/fl mice (Fig 1N–1P). We
compared the expression of the genes in hypertrophic and terminal hypertrophic layers in
femurs and tibiae between Runx2fl/fl and Runx2fl/flCre mice at E15.5 using laser capture micro-
dissection system (Fig 1Q). The Runx2 expression in Runx2fl/flCre mice was severely reduced
and the Col10a1 expression was similar to that in Runx2fl/fl mice. The expression of Mmp13,
Ibsp, Spp1, and Vegfa, which are expressed in terminal hypertrophic chondrocyte layer, in
Runx2fl/flCre mice was less than that in Runx2fl/fl mice (Fig 1R). Further, the expression of Bcl2,
Pten, Fas, and Bnip3 in Runx2fl/flCre mice was higher than that in Runx2fl/fl mice, suggesting
that Pten, Fas, and Bnip3 may be involved in the increased apoptosis in Runx2fl/flCre mice (Fig
1R). These findings indicate that the deletion of Runx2 in the hypertrophic chondrocytes did
not affect the terminal differentiation of chondrocytes, vascular invasion into the calcified car-
tilage, bone collar formation, and the expression of Col10a1, but decreased the expression of
Mmp13, Ibsp, Spp1, and Vegfa in the terminal hypertrophic chondrocytes and increased the
apoptosis of terminal hypertrophic chondrocytes.
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The number of osteoblasts in the bone marrow was markedly reduced and
the formation of primary spongiosa was impaired in Runx2fl/flCre mice at
E16.5
As skeletal development was histologically indistinguishable between Runx2fl/fl and Runx2fl/flCre
mice at E15.5 when vascular invasion into the cartilage starts, the expression of chondrocyte and
osteoblast marker genes was examined by in situ hybridization using femurs at E16.5 when the
primary spongiosa is formed. On H-E staining, the primary spongiosa was formed in Runx2fl/fl
and Runx2fl/+Cre mice but not in Runx2fl/flCre mice (Fig 2A–2C). The expression of Col2a1 and
Col10a1was similar among Runx2fl/fl, Runx2fl/+Cre, and Runx2fl/flCre mice (Fig 2D–2I and 2V).
The expression ofMmp13, which is expressed in terminal hypertrophic chondrocytes, was
reduced in Runx2fl/flCre mice as compared with Runx2fl/fl and Runx2fl/+Cre mice (Fig 2J–2L and
2V). The expression of Ibsp and Spp1was observed in terminal hypertrophic chondrocytes and
osteoblasts in the bone collar and primary spongiosa in Runx2fl/fl and Runx2fl/+Cre mice, whereas
it was observed in terminal hypertrophic chondrocytes and osteoblasts in the bone collar but not
in the bone marrow in Runx2fl/flCre mice (Fig 2M–2R and 2V). The expression of Col1a1, which
is expressed in osteoblasts, was strongly detected in osteoblasts in the bone collar and primary
spongiosa in Runx2fl/fl and Runx2fl/+Cre mice, whereas it was strongly detected in osteoblasts in
the bone collar but almost absent in bone marrow in Runx2fl/flCre mice (Fig 2S–2V). ALP stain-
ing revealed that ALP-positive osteoblasts had accumulated in the bone collar and bone marrow
in Runx2fl/fl mice, and that they were also abundant in the bone collar but almost absent in the
middle of the bone marrow in Runx2fl/flCre mice (Fig 3A and 3B). Runx2-positive osteoblasts and
Sp7-positive osteoblasts were abundant in the bone collar and primary spongiosa in femurs of
Runx2fl/fl mice, whereas they were abundant in the bone collar but markedly reduced in bone
marrow in Runx2fl/flCre mice (Fig 3C–3H). The staining of endothelial cells with anti-CD34 anti-
body indicated that blood vessels invaded into the cartilage at a similar level in Runx2fl/fl and
Runx2fl/flCre mice (Fig 3I–3K). The number of BrdU-positive cells was similar in proliferating
layers of the growth plates in femurs between Runx2fl/fl and Runx2fl/flCre mice, whereas that in
the region of presumptive primary spongiosa in Runx2fl/flCre mice was less than that in Runx2fl/fl
mice (Fig 3L–3O). These findings indicate that the deletion of Runx2 in hypertrophic chondro-
cytes resulted in impaired formation of the primary spongiosa due to the marked reduction of
osteoblasts in bone marrow irrespective of the normal vascular invasion into the cartilage.
Based on safranin O staining of femoral sections, there was more cartilage matrix in bone
marrow in Runx2fl/flCre mice than in Runx2fl/fl mice, although the number of TRAP-positive oste-
oclasts in Runx2fl/flCre mice was higher than that in Runx2fl/fl mice (Fig 3P–3S, 3V and 3W). The
number of TUNEL-positive cells was increased in the safranin O-stained region in the bone mar-
row of Runx2fl/flCre mice compared with Runx2fl/fl mice (Fig 3P’, 3Q’, 3T, 3U and 3X), indicating
again that the deletion of Runx2 in hypertrophic chondrocytes induces apoptosis in terminal
hypertrophic chondrocytes. We compared the expression of Tnfsf11, Tnfrsf11b, and Csf1 using
Fig 1. Skeletal system and histological analyses in Runx2fl/fl and Runx2fl/fl/Cre embryos at E15.5. (A and B) Immunohistochemical analysis in tibia
from Runx2fl/fl (A) and Runx2fl/fl/Cre (B) mice using anti-Runx2 antibody. The boxed regions in A and B are magnified in A’ and B’, respectively. (C)
The number of Runx2-positive hypertrophic chondrocytes was counted and shown. (D and E) Lateral view of the whole skeletons of Runx2fl/fl (D) and
Runx2fl/fl/Cre (E) mice. Hind limbs were magnified in D’ and E’. (F-P) Histological analyses using femoral sections from Runx2fl/fl (F, H, J, L, N) and
Runx2fl/fl/Cre (G, I, K, M, O) mice. (F and G) H-E staining. The boxed regions in F, G, F’, and G’ are magnified in F’, G’, F”, and G”, respectively. (H
and I) von Kossa staining. (J and K) ALP staining. (L and M) Safranin O staining. (N and O) TUNEL staining. (P) The number of TUNEL-positive
hypertrophic chondrocytes was counted. Scale bars: 100 μm (A-B’, F-O), 1 mm (D-E’). The number of mice analyzed: Runx2fl/fl: 4–6, Runx2fl/fl/Cre:
3–5. (Q and R) The expression of the genes related to chondrocyte and osteoclast differentiation and apoptosis in hypertrophic and terminal
hypertrophic layers. (Q) The hypertrophic and terminal hypertrophic layers in femurs and tibiae at E15.5 were isolated using laser capture
microdissection system and RNA was prepared. (R) Real-time RT-PCR analysis. The values in Runx2fl/fl mice were defined as 1, and relative levels are
shown. The number of mice analyzed: Runx2fl/fl: 7, Runx2fl/fl/Cre: 7. Data are the mean ± SD. �Versus Runx2fl/fl, �p<0.05, ��p<0.01, ���p<0.001.
https://doi.org/10.1371/journal.pgen.1009169.g001
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Fig 2. In situ hybridization at E16.5. The femoral sections from Runx2fl/fl (A, D, G, J, M, P, S), Runx2fl/+/Cre (B, E, H, K, N, Q, T), and Runx2fl/fl/Cre (C, F, I, L, O, R, U)
mice were used. (A-C) H–E staining. (D-U) In situ hybridization using Col2a1 (D-F), Col10a1 (G-I), Mmp13 (J-L), Ibsp (M-O), Spp1 (P-R), and Col1a1 (S-U) probes.
The boxed regions in A-U are magnified in A’-U’, respectively. (V) Intensity on in situ hybridization. The gray values in the red boxes in G’-U’ were measured. The gray
values in Runx2fl/fl mice were set as 1, and the relative levels are shown. Scale bars: 100 μm. The number of mice analyzed: Runx2fl/fl: 3–6, Runx2fl/+/Cre: 3, Runx2fl/fl/Cre:
3–5. Data are the mean ± SD. �Versus Runx2fl/fl, #Versus Runx2fl/+/Cre, � ,#p<0.05, �� ,##p<0.01.
https://doi.org/10.1371/journal.pgen.1009169.g002
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Fig 3. Histological analyses of Runx2fl/fl and Runx2fl/fl/Cre embryos at E16.5. The femoral sections from Runx2fl/fl (A, C, E, I, L, P, R, T) and Runx2fl/fl/Cre (B,
D, F, J, M, Q, S, U) mice were used. (A and B) ALP staining. (C-F) Immunohistochemical analysis using anti-Runx2 (C, D) and anti-Sp7 (E, F) antibodies. The
boxed regions in A-F were magnified in A’-F’, respectively. (G and H) The numbers of Runx2 (G)- and Sp7 (H)-positive cells in the red boxes of C’-F’ were
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RNA from the diaphyses of femurs and tibiae at E16.5, which contained hypertrophic and termi-
nal hypertrophic chondrocytes, osteoblasts, and hematopoietic cells. The expression of Tnfsf11,
Tnfrsf11b, and Csf1 and the ratio of Tnfsf11/Tnfrsf11bwere similar between Runx2fl/fl and
Runx2fl/flCre mice (Fig 3Y). However, Tnfsf11 and Csf1 expression and the ratio of Tnfsf11/
Tnfrsf11bwere reduced in the hypertrophic and terminal hypertrophic chondrocytes in Runx2fl/
flCre mice at E15.5 (Fig 1R), which is consistent with the previous finding that Runx2 induces
Tnfsf11 expression [22]. Thus, it was speculated that Tnfsf11 expression was upregulated in the
invaded osteoblast lineage cells by the danger-associated molecular patterns (DAMPs) released
from the necrotic terminal hypertrophic chondrocytes derived from the increased apoptotic ter-
minal hypertrophic chondrocytes in Runx2fl/flCre mice. High mobility group box 1 (Hmgb1) is
one of the DAMPs, which are released from necrotic cells and induce Tnfsf11 expression in osteo-
blast lineage cells by promoting the production of proinflammatory cytokines, including tumor
necrosis factor α (TNF-α), interleukin (IL)-6, and IL-1, in macrophages, dendritic cells, mono-
cytes, and neutrophils [23]. Hmgb1 is normally localized in the nucleus and translocated to the
cytosol with many types of cellular stress [24]. Thus, we examined the localization of Hmgb1 pro-
tein using femoral sections. Unexpectedly, Hmgb1 protein was dominantly localized in cytosol in
hypertrophic and terminal hypertrophic chondrocytes in both Runx2fl/fl and Runx2fl/flCre mice,
and the stained area and intensity were also similar between them (S2 Fig). The cytosolic Hmgb1
in the terminal hypertrophic chondrocytes will be immediately released when their necrosis
occurs and the released Hmbg1 will induce Tnfsf11 expression in osteoblast lineage cells.
Vegfa expression was high in osteoblasts in the bone collar but severely
reduced in the region of presumptive primary spongiosa in Runx2fl/flCre
mice at E16.5
Runx2 has been reported to regulate Vegfa expression and be required for vascular invasion
into the cartilage [8, 9]. However, vascular invasion into the cartilage was normal in Runx2fl/
flCre mice (Figs 1F, 1G and 3I–3K). Thus, we examined Vegfa expression by immunohis-
tochemistry using anti-Vegfa antibody at E16.5 (Fig 4). Osteoblasts in the bone collar of
femurs strongly expressed Vegfa in both Runx2fl/fl and Runx2fl/flCre mice, whereas the expres-
sion of Vegfa was markedly reduced in the region of presumptive primary spongiosa due to
the absence of osteoblasts in Runx2fl/flCre mice at E16.5 (Fig 4H, 4J, 4M, 4O, 4R and 4T).
Transdifferentiation of terminal hypertrophic chondrocytes into
osteoblasts was impaired in Runx2fl/flCre mice
To investigate whether the absence of osteoblasts in the region of presumptive primary spon-
giosa is due to the failure of transdifferentiation of terminal hypertrophic chondrocytes into
counted. (I-K) Immunohistochemical analysis using anti-CD34 antibody. The boxed regions in I and J were magnified in I’ and J’, respectively. The densities of
stained endothelial cells were measured in the boxed region in I and J, the value in Runx2fl/fl mice was set as 1, and the relative levels are shown (K). The
number of mice analyzed: Runx2fl/fl: 3, Runx2fl/fl Cre: 3. (L and M) BrdU labeling. The boxed regions in L were magnified in L’ and L”, and the boxed regions in
M were magnified in M’ and M”. (N and O) Frequencies of BrdU-positive cells. The frequencies of BrdU-positive chondrocytes in the proliferating layers (L’,
M’, N) and those of BrdU-positive cells in the primary spongiosa regions (red boxes in L” and M”, O) were counted. (P and Q) Safranin O staining. The boxed
regions in P and Q were magnified in P’ and Q’, respectively. (R and S) TRAP staining. (T and U) TUNEL staining. Serial sections were used in P and T, and in
Q and U. (V) The percentage of the safranin O-positive area in bone marrow. (W) TRAP-positive cell number in bone marrow. (X) The number of TUNEL-
positive cells. TUNEL-positive cells were counted in the regions that correspond to the boxed regions in P and Q using the serial sections. (Y) Real-time
RT-PCR analysis of the genes related to osteoclastogenesis. RNA was extracted from the diaphysis of femurs and tibiae in Runx2fl/fl and Runx2fl/fl/Cre mice using
razor blade and stereoscopic microscope at E16.5. The values in Runx2fl/fl mice were defined as 1, and the relative levels are shown. Scale bars: 100 μm. The
number of mice analyzed: Runx2fl/fl: 4–5, Runx2fl/fl/Cre: 4 in ALP staining, immunohistochemical analysis, and TUNEL staining. Runx2fl/fl: 8, Runx2fl/fl/Cre: 5 in
BrdU labeling. Runx2fl/fl: 17, Runx2fl/fl/Cre: 15 in safranin O staining. Runx2fl/fl: 9, Runx2fl/fl/Cre: 6 in TRAP staining. Runx2fl/fl: 8, Runx2fl/fl Cre: 6 in real-time
RT-PCR analysis. Data are the mean ± SD. �Versus Runx2fl/fl, �p<0.05, ��p<0.01, ���p<0.001.
https://doi.org/10.1371/journal.pgen.1009169.g003
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osteoblasts, Runx2fl/flCre mice were mated with CAG promoter-LacZ reporter mice to generate
Runx2fl/+Cre LacZ and Runx2fl/flCre LacZ mice. In both Runx2fl/+Cre LacZ and Runx2fl/flCre LacZ
mice at E15.5, hypertrophic chondrocytes and terminal hypertrophic chondrocytes on femoral
sections were stained by β-galactosidase (Fig 5A–5H, S3A Fig). Before vascular invasion into
the cartilage, Col1a1-positive cells were present in the bone collar, but not in the terminal
hypertrophic chondrocyte layer of femurs, in both Runx2fl/+Cre LacZ and Runx2fl/flCre LacZ mice,
suggesting that the transdifferentiation of terminal hypertrophic chondrocytes into osteoblasts
does not occur before vascular invasion into the cartilage (S3D and S3E Fig). At E16.5 and
E17,5, the number of β-galactosidase-positive cells in the region of primary spongiosa in
Runx2fl/flCre LacZ mice was significantly lower than that in Runx2fl/+Cre LacZ mice (Fig 5I–5U,
S3B and S3C Fig). The β-galactosidase-positive cells in Runx2fl/+Cre LacZ mice were morpholog-
ically terminal hypertrophic chondrocytes or osteoblast lineage cells, whereas those in Runx2fl/
flCre LacZ mice were morphologically terminal hypertrophic chondrocytes (Fig 5Q–5T). These
findings indicate that the absence of primary spongiosa and osteoblasts in the region of pre-
sumptive primary spongiosa in Runx2fl/flCre LacZ mice was due to the impaired transdifferentia-
tion of terminal hypertrophic chondrocytes into osteoblasts.
To more precisely evaluate the transdifferentiation of chondrocytes into osteoblasts, we
mated Runx2fl/flCre mice with Rosa26-CAG-loxP-mTFP1 (Rosa) reporter mice [25] and
2.3 kb Cola1 promoter-tdTomato (tomato) mice to generate Runx2fl/+Cre Rosa tomato mice
Fig 4. Vegfa expression in Runx2fl/fl and Runx2fl/fl/Cre embryos at E16.5. H–E staining (A, D, F, I, K, N, P, S) and immunohistochemical analysis using anti-
Vegfa antibody (C, E, H, J, M, O, R, T) or same working concentration of normal mouse IgG (B, G, L, Q) of femoral sections from Runx2fl/fl (A-C, F-H, K-M,
P-R) and Runx2fl/fl/Cre (D, E, I, J, N, O, S, T) mice. The boxed regions in A-E were magnified in F-J, respectively. The boxed regions in F-J were magnified in K
and P, L and Q, M and R, and N and S, and O and T, respectively. Scale bars: 100 μm. The number of mice analyzed: Runx2fl/fl: 2, Runx2fl/fl/Cre: 2.
https://doi.org/10.1371/journal.pgen.1009169.g004
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and Runx2fl/flCre Rosa tomato mice. The 2.3 kb Cola1 promoter-tdTomato mice, which we
newly generated, showed the tdTomato expression specifically in osteoblasts (S4 Fig). In
Fig 5. β-galactosidase staining of femoral sections from Runx2fl/+/Cre LacZ and Runx2fl/fl/Cre LacZ mice at E15.5, E16.5, and E17.5. β-galactosidase
staining of femoral sections from Runx2fl/+/Cre LacZ (A, I, K) and Runx2fl/fl/Cre LacZ (C, J, L) mice at E15.5 (A, C), E16.5 (I, J), and E17.5 (K, L). The boxed
regions in A, E, B, C, G, D, I, M, J, N, K, O, L, and P were magnified in E, B, F, G, D, H, M, Q, N, R, O, S, P, and T, respectively. The cells in the boxes in
Q, R, S, and T were magnified in the windows. (U) The number of β-gal positive cells in Q and R. Scale bars: 100 μm. The number of mice analyzed:
Runx2fl/+/Cre LacZ: 2, Runx2fl/fl/Cre LacZ: 3 at E15.5. Runx2fl/+/Cre LacZ: 5, Runx2fl/fl/Cre LacZ: 8 at E16.5. Runx2fl/+/Cre LacZ: 4, Runx2fl/fl/Cre LacZ: 2 at E17.5.
Data are the mean ± SD. �Versus Runx2fl/+/Cre LacZ, ��p<0.01.
https://doi.org/10.1371/journal.pgen.1009169.g005
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Runx2fl/+Cre Rosa tomato mice and Runx2fl/flCre Rosa tomato mice, osteoblasts showed red fluo-
rescence (tomato+), the cells derived from hypertrophic chondrocytes showed teal (blue-
green) fluorescence (mTFP+), and the osteoblasts derived from hypertrophic chondro-
cytes showed whitish fluorescence (tomato+mTFP+) on femoral sections by confocal
microscope (Figs 6 and 7). We counted the number of these cells and calculated the per-
centages of the osteoblasts derived from hypertrophic chondrocytes in total osteoblasts
(tomato+mTFP+/tomato+). About 30%, 20%, and 15% of osteoblasts in the trabecular
bone was derived from chondrocytes in control Runx2fl/+Cre Rosa tomato mice at E17.5, new-
born, and 1 week of age, respectively, whereas they were 1–3% in Runx2fl/flCre Rosa tomato
mice (Fig 6). In the endosteum of cortical bone at 1 week of age, about 4% of osteoblasts
was derived from chondrocytes in Runx2fl/+Cre Rosa tomato mice but they were absent in
Runx2fl/flCre Rosa tomato mice (Fig 7A–7G). At 3 weeks of age, about 15% of osteoblasts in
the trabecular bone and in the endosteum of cortical bone in Runx2fl/+Cre Rosa tomato mice
was derived from chondrocytes (Fig 7H–7Q). Further, osteoblasts derived from chondro-
cytes were present in the secondary ossification center of femurs in Runx2fl/+Cre LacZ mice
but they were virtually absent in that in Runx2fl/flCre LacZ mice at 3 weeks of age (S5A–S5C
Fig).
The primary spongiosa was formed along with the appearance of
osteoblasts in the region in Runx2fl/flCre mice, but it was less developed than
that in Runx2fl/fl mice at E17.5 and the newborn stage
To investigate the physiological effects of the impaired transdifferentiation, bone development
was examined in Runx2fl/flCre mice at E17.5 and the newborn stage. Although the cartilage
matrix stained with safranin O was similarly observed in the region of the primary spongiosa
in femurs of Runx2fl/flCre mice and Runx2fl/fl mice at E17.5, Ibsp, Col1a1, and Bglap2 expression
was significantly lower and Spp1 expression was marginally lower in the region of the primary
spongiosa in femurs or tibiae in Runx2fl/flCre mice than in Runx2fl/fl mice (Fig 8A–8Q), demon-
strating that the primary spongiosa is less developed in Runx2fl/flCre mice than in Runx2fl/fl
mice. Immunohistochemical analysis using femoral sections revealed Runx2-positive osteo-
blasts and Sp7-positive osteoblasts in the region of primary spongiosa in Runx2fl/flCre mice, but
their number was less than that in Runx2fl/fl mice at E17.5 (Fig 8R–8W).
At the newborn stage, primary spongiosa developed further, and the number of Runx2-po-
sitive cells and the expression of Col1a1 and Bglap2 in the primary spongiosa in femurs of
Runx2fl/flCre mice reached a similar level to those of Runx2fl/fl mice (Fig 9A–9K). The physical
appearance and body weight were similar between Runx2fl/fl and Runx2fl/flCre newborn mice
(Fig 9L, 9M and 9R). On micro-CT analysis, the total bone volume and total trabecular bone
volume of femurs were similar between Runx2fl/fl and Runx2fl/flCre newborn mice (Fig 9N–9Q,
9S and 9T). However, the bone volume of the secondary spongiosa in Runx2fl/flCre newborn
mice was less than that in Runx2fl/fl newborn mice (Fig 9P, 9Q and 9U).
The trabecular bone volume reached a normal level in Runx2fl/flCre mice by
6 weeks of age
The physical appearance and body weight were similar between Runx2fl/fl and Runx2fl/flCre
females at 6 weeks and males at 20 weeks of age (Fig 10A–10C and 11A–11C). Micro-CT anal-
ysis demonstrated that all of the parameters of trabecular bone in the primary and secondary
ossification centers, including bone volume, trabecular thickness, trabecular number, and tra-
becular bone mineral density (BMD), were similar in femurs between Runx2fl/fl and Runx2fl/
flCre mice at 6 weeks and 20 weeks of age (Fig 10D–10G, 10L, 10M, 11D–11G, 11L and 11M).
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The parameters of cortical bone, including cortical volume (CtAr/TtAr), cortical thickness (Ct.
Th), and cortical BMD (BMD), in femurs were also similar between Runx2fl/fl and Runx2fl/flCre
mice at 6 weeks and 20 weeks of age (Fig 10H, 10I, 10N, 11H, 11I and 11N). Furthermore, the
parameters of trabecular bones in the first lumbar vertebrae were similar between Runx2fl/fl and
Runx2fl/flCre mice at 6 weeks and 20 weeks of age (Fig 10J, 10K, 10O, 11J, 11K and 11O).
In bone morphometric analysis of cortical bone at 6 weeks and 20 weeks of age, the mineral
apposition rate, mineralizing surface, and bone formation rate were similar between Runx2fl/fl
and Runx2fl/flCre mice in both the endosteum and periosteum (Fig 10P–10W and 11P–11W).
We also preformed bone histomorphometric analysis of trabecular bone of vertebrae in
females at 6 weeks and 12 weeks of age and tibiae in females at 12 weeks of age. All parameters
for osteoblasts, osteoclasts, and bone resorption and formation were similar between Runx2fl/fl
and Runx2fl/flCre mice (Fig 12). Finally, we performed three-point bending tests to evaluate the
bone strength using the female femurs at 12 weeks of age. The parameters, including maxi-
mum load, displacement, stiffness, and energy to failure, were similar between Runx2fl/fl and
Runx2fl/flCre mice (Fig 13).
Discussion
The process of endochondral ossification, including terminal differentiation of chondrocytes
and vascular invasion into the cartilage, was normal in Runx2fl/flCre mice, although the expres-
sion of Mmp13, Ibsp, Spp1, and Vegfa in the terminal hypertrophic chondrocytes was reduced.
However, transdifferentiation of the terminal hypertrophic chondrocytes into osteoblasts was
impaired in Runx2fl/flCre mice, and apoptosis of terminal hypertrophic chondrocytes was
increased in Runx2fl/flCre mice before the transdifferentiation in Runx2fl/fl mice. The osteoblasts
derived from chondrocytes were about 15–30% of total osteoblasts in the trabecular bone and
4–15% in the endosteum of cortical bone in control Runx2fl/+Cre mice, whereas those were
about 1–3% in the trabecular bone and absent in the cortical bone in Runx2fl/flCre mice (Figs 6
and 7). Runx2fl/flCre mice lacked osteoblasts in the region of presumptive primary spongiosa
and failed to form the primary spongiosa at E16.5. However, osteoblasts, which likely origi-
nated from the perichondrium/periosteum, were observed in the region of presumptive pri-
mary spongiosa in Runx2fl/flCre mice at E17.5, the number of osteoblasts became similar to that
in Runx2fl/fl mice at birth, and the bone volume of the primary spongiosa but not secondary
spongiosa became similar. In addition, all of the bone parameters, including trabecular and
cortical bone, became similar between Runx2fl/flCre and Runx2fl/fl mice at 6 weeks of age, and
the bone was maintained thereafter acquiring normal strength. Thus, our findings demon-
strate that Runx2 is required for the survival of terminal hypertrophic chondrocytes and their
transdifferentiation into osteoblasts, that this transdifferentiation is transiently required for
forming the primary spongiosa, and that osteoblasts, which have most likely originated from
the perichondrium/periosteum, can compensate for the lack of transdifferentiation, leading to
normal bone mass in Runx2fl/flCre mice at 6 weeks of age.
Fig 6. Tracing of the transdifferentiated osteoblasts in trabecular bone at E17.5, newborn, and one week of age. Frozen femoral sections from
Runx2fl/+Cre ROSA tomato (A, C, E, G, I, K, M, O, Q) and Runx2fl/flCre ROSA tomato (B, D, F, H, J, L, N, P, R) mice at E17.5 (A-F), newborn (G-L), and 1
week of age (M-R) were observed by confocal microscopy. Osteoblasts express tdTomato (red), the cells derived from hypertrophic chondrocytes
express mTFP (blue-green), and the osteoblasts derived from hypertrophic chondrocytes exhibit their merged whitish color. The boxed regions in
A-R and A’-R’ are magnified in A’-R’ and A”-R”, respectively. Arrows show the osteoblasts derived from hypertrophic chondrocytes. Scale bars:
500 μm (A-R), 100μm (A’-R’), and 50μm (A”-R”). (S-U) The number of tdTomato-positive (t+) cells and tdTomoto- and mTFP-double positive
(t+m+) cells were counted in trabecular bone, and the percentages of t+m+ cells in t+ cells were calculated at E17.5 (S), newborn (T), and 1 week of
age (U). Arrows show t+m+ cells. The number of mice analyzed: Runx2fl/+Cre Rosa tomato: 3–4, Runx2fl/flCre Rosa tomato: 3–4. Data are the mean ± SD.
�Versus Runx2fl/+ Cre Rosa tomato, �p<0.05, ��p<0.01, ���p<0.001.
https://doi.org/10.1371/journal.pgen.1009169.g006
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Fig 7. Tracing of the transdifferentiated osteoblasts in cortical bone at 1 week of age, and trabecular and cortical bone at 3 weeks of age. (A-G) Cortical
bone in frozen femoral sections in Runx2fl/+Cre Rosa tomato (A, C, E) and Runx2fl/flCre Rosa tomato (B, D, F) mice at 1 week of age. The boxed regions in A-F and
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Runx2–/–mice die at birth and have cartilaginous skeletons due to the impaired chondrocyte
maturation and the absence of osteoblasts [2, 5–7]. In most skeletons of Runx2–/–mice, hyper-
trophic chondrocytes are absent. However, maturation of hypertrophic chondrocytes into ter-
minal hypertrophic chondrocytes normally proceeded in Runx2fl/flCre mice, although the
terminal hypertrophic chondrocytes expressed Mmp13, Ibsp, Spp1, and Vegfa, which are target
genes of Runx2 [26], at reduced levels as compared with those in Runx2fl/fl mice. Thus, Runx2
is indispensable for the expression of Mmp13, Ibsp, Spp1 and Vegfa at the physiological levels
in terminal hypertrophic chondrocytes but dispensable for the final maturation of hypertro-
phic chondrocytes into terminal hypertrophic chondrocytes.
In the restricted skeletons of Runx2–/–mice, including the tibia, fibula, radius, and ulna, the
cartilage matrix is mineralized and chondrocytes are terminally differentiated [2, 5]. However,
vascular invasion into the calcified cartilage is absent in Runx2–/–mice and Vegfa expression in
the terminal hypertrophic chondrocytes is reduced [8, 9]. Therefore, Runx2 has been consid-
ered to induce the vascular invasion into the cartilage by regulating Vegfa expression in termi-
nal hypertrophic chondrocytes [27]. Vegfa conditional knockout mice using Col2a1-Cre,
which directs the transgene expression to chondrocytes and perichondral cells, showed
delayed vascular invasion into the cartilage [28]. The delayed vascular invasion is due to the
lack of Vegfa expression in the terminal hypertrophic chondrocytes and perichondrial osteo-
blasts, both of which strongly express Vegfa. Similarly, Vegfa conditional knockout mice using
Sp7-Cre, which directs the transgene expression to prehypertrophic chondrocytes and preos-
teoblasts in the perichondrium, showed delayed vascular invasion into the cartilage [29]. The
delayed vascular invasion is also due to the lack of Vegfa expression in terminal hypertrophic
chondrocytes and perichondrial osteoblasts. Vegfa expression in the terminal hypertrophic
chondrocytes was reduced in Runx2–/–mice and Runx2fl/flCre mice, but vascular invasion into
the cartilage never occurs in Runx2–/–mice but normally occurred in Runx2fl/flCre mice (Fig 1F,
1G and 1R, Fig 3I–3K) [2, 5–8]. The difference of the two mouse models is the presence of
perichondrial osteoblasts in Runx2fl/flCre mice but their absence in Runx2–/–mice (Fig 4H, 4J,
4M and 4O) [6, 7]. These findings indicate that Vegfa expression in perichondrial osteoblasts
is sufficient for the vascular invasion into the cartilage. The importance of the perichondrium
for the vascular invasion into the cartilage was also shown by ex vivo experiments transplant-
ing cartilaginous anlagen of long bones into the renal capsule of adult mice [30]. However, the
increased apoptosis of terminal hypertrophic chondrocytes in Runx2fl/flCre mice may have pro-
moted the vascular invasion into the cartilage because apoptotic terminal hypertrophic chon-
drocytes may finally die by necrosis without phagocytosis and release DAMPs, which induce
osteoclastogenesis [23, 31]. Indeed, there were more osteoclasts in Runx2fl/flCre mice than in
Runx2fl/fl mice at E16.5, although Tnfsf11 and Csf1 expression was reduced in the terminal
hypertrophic chondrocytes (Figs 1R, 3R, 3S and 3W). The increased osteoclasts may also have
facilitated the invasion of preosteoblasts in the perichondrium into the cartilage by removing
the cartilage matrix. Furthermore, vascular invasion into the cartilage is likely required for the
A’-F’ were magnified in A’-F’ and A”-F”, respectively. The number of tdTomato-positive (t+) cells and tdTomoto- and mTFP-double positive (t+m+) cells
were counted in the endosteum of cortical bone, and the percentages of t+m+ cells in t+ cells were calculated (G). (H-P) Trabecular (H, K, N) and cortical (J,
M, P) bone in the frozen femoral sections in Runx2fl/+Cre Rosa tomato mice at 3 weeks of age. The boxed region in H, I, I’, J, J’, K, L, L’, M, M’, N, O, O’, P, and
P’ were magnified in I, I’, I”, J’, J”, L, L’, L”, M’, M”, O, O’, O”, P’, and P”, respectively. The number of tdTomato-positive (t+) cells and tdTomoto- and
mTFP-double positive (t+m+) cells were counted in the trabecular bone and in the endosteum of cortical bone, and the percentages of t+m+ cells in t+ cells
were calculated (Q). Arrows show t+m+ cells. Scale bars: 1mm (H, K, N), 500 μm (A-F, I, J, L, M, O, P), 100 μm (A’-F’, I’, J’, L’, M’, O’, P’), and 50 μm (A”-F”,
I”, J”, L”, M”, O”, P”). The number of mice analyzed: Runx2fl/+Cre Rosa tomoto: 3–4, Runx2fl/flCre Rosa tomato: 3–4. �Versus Runx2fl/+Cre Rosa tomato, �p<0.05,
��p<0.01.
https://doi.org/10.1371/journal.pgen.1009169.g007
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transdifferentiation of terminal hypertrophic chondrocytes because it was not observed before
vascular invasion.
The major source of bone marrow osteoblasts has long been debated. The transdifferen-
tiation of chondrocytes to osteoblasts was confirmed using Col10a1 Cre, which is expressed
in hypertrophic chondrocytes, but not in perichondrial/periosteal cells [16–19]. Further-
more, Pthlh-positive chondrocytes in the resting zone of the growth plate were reported to
become osteoblasts and stromal cells in bone marrow, and to be able to differentiate to
chondrocytes, osteoblasts, and adipocytes in vitro [32]. These findings suggest that the
transdifferentiated stroma cells and osteoblasts are major sources of osteoblasts in bone
marrow, and play an important role in trabecular and cortical bone formation. Cell-lineage
tracing experiments using Sp7 CreER, Col2a1 CreER, Sox9 CreER, Acan CreER, which are
expressed in perichondrial/periosteal cells and chondrocytes, indicate that the origin of
osteoblasts in bone marrow is perichondrial/periosteal cells and/or chondrocytes [33, 34].
Therefore, the osteoblasts in the primary spongiosa in Runx2fl/flCre mice after E17.5 must
have originated from perichondrial/periosteal cells. Although the primary spongiosa forma-
tion in Runx2fl/flCre mice was similar to that in Runx2fl/fl mice at birth, the secondary spon-
giosa formation in Runx2fl/flCre mice was markedly retarded. The structure and volume of
trabecular bone in Runx2fl/flCre mice became similar to those in Runx2fl/fl mice by 6 weeks
of age. Thus, our findings indicate that chondrocyte transdifferentiation is required for tra-
becular bone formation at embryonic and neonatal stages, but dispensable for acquiring
normal bone mass and structure in young and adult mice, and that osteoblasts originating
from perichondrial/periosteal cells play a major role in trabecular and cortical bone forma-
tion at least after birth. It was reported that borderline chondrocytes, which are located
adjacent to the perichondrium, differentiate to osteoblasts and stromal cells [35]. Although
the borderline chondrocytes express Col10a1 before differentiation to osteoblasts [35],
Runx2fl/flCre Rosa tomato mice had very low number of osteoblasts derived from chondrocytes.
Therefore, the differentiation of borderline chondrocytes to osteoblasts was considered to
have been impaired in Runx2fl/flCre mice.
In conclusion, Runx2 maintained the survival of terminal hypertrophic chondrocytes and
was required for their transdifferentiation into osteoblasts. This transdifferentiation was
required for trabecular bone formation in embryonic and neonatal stages, but osteoblasts orig-
inating from the perichondrium/periosteum were considered to play a major role in trabecular
bone formation at least after birth. The molecular mechanism of chondrocyte transdifferentia-
tion to osteoblasts needs to be further investigated.
Materials and methods
Ethics statement
Before the study, all experimental protocols were reviewed and approved by the Animal Care
and Use Committee of Nagasaki University Graduate School of Biomedical Sciences (No.
1903131520–2).
Fig 8. Histological analyses of Runx2fl/fl and Runx2fl/fl/Cre embryos at E17.5. Femoral (A-J, R-U) and tibial (K, L) sections from Runx2fl/fl (A, C, E, G, I,
K, R, T) and Runx2fl/fl/Cre (B, D, F, H, J, L, S, U) mice were used for the analyses. (A and B) H–E staining. (C and D) Safranin O staining. (E–L) In situ
hybridization using Ibsp (E, F), Spp1 (G, H), Col1a1 (I, J), and Bglap2 (K, L) probes. (M) The percentage of the safranin O-positive area in red boxes of C’
and D’. (N–Q) Intensity of in situ hybridization using Ibsp, Spp1, Col1a1, and Bglap2 probes. The gray values in the red boxes in E’–L’ were measured.
The gray values in Runx2fl/fl mice were set as 1, and the relative levels are shown. (R-U) Immunohistochemical analysis using anti-Runx2 (R, S) and anti-
Sp7 (T, U) antibodies. The boxed regions in A-L, R-U, and R’-U’ were magnified in A’-L’, R’-U’, and R”-U”, respectively. Scale bars: 100 μm. (V, W) The
number of Runx2-positive cells in R” and S” (V) and Sp7-positive cells in T” and U” (W). The number of mice analyzed: Runx2fl/fl: 4–7, Runx2fl/fl/Cre:
4–7. Data are the mean ± SD. �Versus Runx2fl/fl, �p<0.05.
https://doi.org/10.1371/journal.pgen.1009169.g008
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Generation of Runx2fl/fl/Cre mice and 2.3 kb Cola1 promoter-tdTomato
transgenic mice
Exon 3 of Runx2 previously described as exon 1 [6], which encodes the N-terminal region and
a part of Runt domain of Runx2 protein was conditionally deleted. The targeting vector har-
boring the exon 3 and a FRT-flanked neomycin resistance gene (Neo), both of which are
flanked by Loxp sites was electroporated into Bruce-4 ES cells (C57BL/6). Digested genomic
DNA of targeted ES cells was subjected to Southern blot using 5’ or 3’ alkaline phosphatase-
labelled probes (429bp or 387bp), which were generated by polymerase chain reaction (PCR)
using 5’-GATAGAATGATTTCAAGGAGGAGTG-3’ and 5’-CTTGTAACTGCGTTATGAAA
CTTGA-3’ or 5’-AAGGAGACTTTTAAGCTTCAGACAT-3’ and 5’-AAAGGATTCCTGAG
AGTGAAATACA-3’ primers, respectively. To remove the FRT-flanked Neo, the offspring
(F1) was crossed with CAG-FLP transgenic mice (C57BL/6). Floxed and wild-type alleles of
Runx2flox/+ mice were detected by PCR using 5’-ACTTCGGTTGGTCAGAATAAACAG-3’
and 5’-CAAGCTAACGGGACTTG GAAGAG-3’ primers (327 bp and 173 bp, respectively).
Runx2fl/fl mice were mated with Col10a1-Cre transgenic mice [21] to generate Runx2fl/fl/Cre
mice. The background of Runx2fl/fl mice and Col10a1-Cre transgenic mice was C57BL/6. To
generate 2.3k Col1a1 promoter-tdTomato transgenic mice, a 1456-bp tdTomato (Addgene,
Watertown, CM) fragment was cloned into the NotI site of a pNASSβ expression vector (Clon-
tech, Mountain View, CA), which contained the 2.3-kb Col1a1 promoter region. The construct
DNA was injected into the pronuclei of fertilized eggs from C57BL/6 mice. Transgenic mice
were identified by genomic PCR using 5’-ATGCGGCCGCATCCACCGGTCGCCACCAT-3’
and 5’-ATGCGGCCGCTTACTTGTACAGCT-3’ primers. A transgenic line was maintained
in the C57BL/6 background. Rosa26-CAG-loxP-mTFP1 reporter mice with C57BL/6 back-
ground were obtained from RIKEN Bioresource Research Center [25]. Animals were housed 3
per cage in a pathogen-free environment on a 12-h light cycle at 22±2˚C with standard chow
(CLEA Japan, Tokyo, Japan) and had free access to tap water.
Histological analyses
For histological analyses, mice were fixed in 4% paraformaldehyde/0.1 M phosphate buffer,
and embedded in paraffin. Sections of 4 or 7 μm in thickness were stained with H-E, von
Kossa, or TRAP. TUNEL staining was performed using the ApopTag Peroxidase In Situ Apo-
ptosis Detection Kit (Sigma Aldrich, St. Louis, MO). To analyze BrdU incorporation, we sub-
cutaneously injected BrdU into the back of pregnant mice at E16.5 at 100 μg/g body weight 1 h
before sacrifice, and detected BrdU incorporation using a BrdU staining kit (Invitrogen, Carls-
bad, CA). The sections were counterstained with hematoxylin. For safranin O staining, the sec-
tions were stained with hematoxylin, fast green, and safranin O. The area positive for TRAP or
safranin O was measured by ImageJ (National Institute of Health). Immunohistochemistry
was performed using polyclonal rabbit anti-Col1a1 (Rockland, Limerick, PA), monoclonal
Fig 9. Histological and micro-CT analyses of Runx2fl/fl and Runx2fl/flCre newborn mice. The femoral sections from Runx2fl/fl (A, C, F, H) and
Runx2fl/fl/Cre (B, D, G, I) mice were used for histological analyses. (A and B) H–E staining. (C and D) Immunohistochemical analysis using anti-
Runx2 antibody. (E) The number of Runx2-positive cells in C” and D”. (F-I) In situ hybridization using Col1a1 and Bglap2 probes. (J and K)
Intensity of in situ hybridization using the Col1a1 probe in F’ and G’(J) and Bglap2 probe in H’ and I’ (K). The values in Runx2fl/fl mice were set as 1,
and the relative levels are shown. (L, M) Physical appearance of Runx2fl/fl and Runx2fl/flCre mice. (N-Q) Micro-CT images of whole femurs (N, O) and
the trabecular bone (P, Q) in Runx2fl/fl (N, P) and Runx2fl/flCre (O, Q) mice. (R) Body weight of Runx2fl/fl and Runx2fl/flCre mice. (S-U) The percentage
of the total bone volume/total tissue volume in N and O (S), that of total trabecular bone volume/total tissue volume in P and Q (T), and that of
secondary spongiosa volume/tissue volume in the red boxes in P and Q (U). The boxed regions in A, B, C, D, C’, D’, F, G, H, and I are magnified in
A’, B’, C’, D’, C”, D”, F’, G’, H’, and I’, respectively. Scale bars: 100 μm (A-D”, F-I’), 0.5 cm (L, M), 0.5 mm (N-Q). The number of mice analyzed:
Runx2fl/fl: 4–7, Runx2fl/fl/Cre: 3–4. Data are the mean ± SD. �Versus Runx2fl/fl, �p<0.05.
https://doi.org/10.1371/journal.pgen.1009169.g009
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rabbit anti-Runx2 (Cell Signaling, Danvers, MA), polyclonal rabbit anti-Sp7 (Abcam, Cam-
bridge, UK), and monoclonal mouse anti-VEGF (Santa Cruz, Dallas, TX) antibodies. The sec-
ondary antibodies were Histofine Stain MAXPO (R) (Nichirei, Tokyo, Japan) for the former
three and Histofine Mouse Stain Kit (Nichirei) for the last. We carried out in situ hybridization
using mouse Col2a1, Col10a1, Ibsp, Mmp13, Spp1, Col1a1, and Bglap2 antisense probes as
described previously [2]. The intensities on in situ hybridization were measured by ImageJ. In
von Kossa, TUNEL, in situ hybridization, and immunohistochemical analyses, the sections
were counterstained with methyl green. For ALP staining, CD34 immunohistochemistry, and
the analyses by confocal microscopy, embryos and postnatal mice were euthanized and fixed
with 4% paraformaldehyde at 4˚C for 2 hours, washed with PBS at 4˚C for 1 hour, immersed
in 20% sucrose at 4˚C overnight, embedded in O. C. T. compound (Sakura Finetek, Tokyo,
Japan), frozen in a refrigerated installation (Rikakikai UT-2000F, Tokyo, Japan) containing
-100˚C hexane and pentane (10:3), and sectioned at 7-μm thickness using Leica CM3050S
(Leica Biosystems, Tokyo, Japan). For ALP staining, the cryosections were stained with the
solution containing 0.1 mg/ml of Naphthol AS–MX phosphate (Sigma Aldrich), 0.05% N, N–
dimethylformamide (Wako, Osaka, Japan), 0.1 M Tris–Hcl (PH: 8.5), and 0.6 mg/ml of Fast
BB salt (Sigma Aldrich). The sections were mounted without alcohol treatment after counter-
staining with nuclear fast red. The cryosections were also used for immunohistochemistry
using anti-CD34 antibody (Hycult Biothech, Uden, Netherlands), and the secondary antibody,
Histofine Stain MAXPO (Rat) (Nichirei, Tokyo, Japan). The sections were counterstained
with methyl green. The density of blood vessels at the diaphysis of femurs was quantified using
Image J software based on CD34 staining. Fluorescent images of tdTomato and mTFP were
acquired by confocal microscopy (LSM 800, ZEISS, Oberkochen, Germany). To examine the
expression of the LacZ reporter gene, whole mount β-galactosidase staining was performed for
Runx2fl/+Cre LacZ and Runx2fl/flCre LacZ mice at E15.5, E16.5, and E17.5. Limbs were dissected
from embryos and fixed with 4% paraformaldehyde/0.1 M phosphate buffer by immersion at
4˚C for 1 h. After washing with PBS 3 times for 1 h, the limbs were incubated in X-Gal solution
containing 0.1 M phosphate buffer (pH 7.4), 1 mg/ml of X-gal, 5 mM K3Fe(CN)6, 5 mM K4Fe
(CN)6, and 2 mM MgCl2 at 37˚C overnight with gentle shaking. After staining, the limbs
from embryos were decalcified with 10% EDTA for 24 h. After dehydration, the limbs were
embedded in paraffin and sectioned at 7-μm thickness. The sections were counterstained with
eosin.
Laser capture microdissection and real-time reverse transcription
(RT)-PCR
The hind limbs at E15.5 were separated from embryos and immediately embedded in O. C. T.
compound (Sakura Finetek, Tokyo, Japan), and stored at –80˚C. The blocks were sectioned at
Fig 10. Micro-CT and bone histomorphometric analyses of Runx2fl/fl and Runx2fl/flCre female mice at 6 weeks of age. (A, B) Physical
appearance of Runx2fl/fl (A) and Runx2fl/flCre (B) mice. (C) Body weight. (D-K) Three-dimensional images of trabecular bone in the primary
ossification center (D, E), trabecular bone in the secondary ossification center (F, G), and cortical bone at mid-diaphysis (H, I) in femurs, and
those of trabecular bone in first lumbar vertebrae (J, K) in Runx2fl/fl (D, F, H, J) and Runx2fl/flCre (E, G, I, K) mice. The views from the top are
shown for the trabecular bone in the secondary ossification center (F, G). (L-O) Trabecular bone volume (BV/TV), trabecular thickness (Tb.Th),
trabecular number (Tb.N), and trabecular bone mineral density (BMD) in the primary ossification center (L), secondary ossification center (M),
and first lumber vertebrae (O); and cortical area (CtAr/TtAr), cortical thickness (Ct.Th), and cortical bone mineral density (BMD) at mid-
diaphysis of femurs (N). (P-W) Bone histomorphometric analyses of cortical bone. Cross-sections from the mid-diaphyses of femurs in Runx2fl/fl
(P, R, S) and Runx2fl/fl Cre mice (Q, T, U), in which calcein had been injected twice, were analyzed. R and T show periosteum (per) and S and U
show endosteum (end). (V, W) Mineral apposition rate (MAR), mineralizing surface (MS/BS), and bone formation rate (BFR/BS) in the
periosteum (V) and endosteum (W). BS, bone surface. Scale bars: 1 cm (A, B), 1 mm (D-K), 200 μm (P, Q) and 100 μm (R–U). The number of
mice analyzed: Runx2fl/fl: 12, Runx2fl/fl/Cre: 10. Data are the mean ± SD.
https://doi.org/10.1371/journal.pgen.1009169.g010
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10 μm thickness using Leica CM3050S (Leica, Wetzlar, Germany). The sections were fixed in
cold ethanol/acetic acid (19:1) for 3 minutes, washed twice with DDW, then kept in 100% eth-
anol on ice for laser capture microdissection. Hypertrophic and terminal hypertrophic chon-
drocyte layers were collected using Leica LMD7 (Leica, Wetzlar, Germany), and RNA was
extracted using Arcturus PicoPure RNA Isolation Kit (Thermo Fisher Scientific, Waltham,
CM). Real-time RT-PCR was performed using a THUNDERBIRD SYBR qPCR Mix (Toyobo,
Osaka, Japan) and Light Cycler 480 q-PCR machine (Roche Diagnostics, Tokyo, Japan).
Primer sequences are shown in S1 Table. We normalized the values obtained to those of Actb.
Skeletal and micro-CT analyses
Skeletal preparations were performed as described previously [6]. Quantitative micro-CT anal-
ysis was performed using a micro-CT system (R_mCT, Rigaku Corporation, Tokyo, Japan).
Data from scanned slices were used for 3-dimensional analysis to calculate morphometric
parameters in femurs and first lumbar vertebrae. Femoral trabecular bone parameters were
measured on a distal femoral metaphysis, and approximately 2.4 mm (0.5 mm far from the
growth plate) was cranio-caudally scanned and 200 slices in 12-μm increments were taken at 6
and 20 weeks of age. Thirty slices were taken in the regions in the secondary calcification cen-
ter of femurs at 6 and 20 weeks of age, as shown in S5D–S5G Fig. For analysis of the first lum-
bar vertebrae, 65 and 100 slices were taken at 6 and 20 weeks of age, respectively. For analysis
of newborn mice, 260 slices were taken in the whole femurs and 60 slices were taken in the sec-
ondary spongiosa. The threshold of the mineral density was 500 mg/cm3 at 6 and 20 weeks of
age, and 300 mg/cm3 at the newborn stage.
Bone histomorphometric analysis
Mice were intraperitoneally injected 20 mg per kg body weight of calcein at either 5 and 2 d or
7 and 2 d before sacrifice in the analysis of 6- or 12-week-old mice, respectively. Mice were
euthanized, and the right tibiae and lumbar vertebrae (L3-L5) were harvested and fixed in 70%
ethanol for 3 days. Fixed bones were dehydrated with graded ethanol and infiltrated and
embedded in the mixture of methylmethacrylate and 2-hydroxyethyl methacrylate (both from
Fujifilm Wako pure chemical, Osaka, Japan). Undecalcified 4-μm-thick sections were obtained
with a microtome and left unstained for the measurement of fluorochrome labeling. Consecu-
tive sections were stained with either von Kossa method for image capture using cellSens soft-
ware (Olympus, Tokyo, Japan) or 0.05% toluidine blue (pH7.0) for the measurement of
osteoid, osteoblasts and osteoclasts. The bone histomorphometric analysis was performed in
proximal tibiae and lumbar vertebra under 200X magnification within a 0.75 mm high X 0.7
mm wide region located 300 μm apart from the growth plate using Histometry RT camera ana-
lyzing software (System-supply, Nagano, Japan). 20-μm cross sections from mid-diaphyses of
Fig 11. Micro-CT and bone histomorphometric analyses of Runx2fl/fl and Runx2fl/flCre male mice at 20 weeks of age. (A, B) Physical appearance
of Runx2fl/fl (A) and Runx2fl/flCre (B) mice. (C) Body weight. (D-K) Three-dimensional images of trabecular bone in the primary ossification center
(D, E), trabecular bone in the secondary ossification center (F, G), and cortical bone at mid-diaphysis (H, I) in femurs, and those of trabecular bone
in first lumbar vertebrae (J, K) in Runx2fl/fl (D, F, H, J) and Runx2fl/flCre (E, G, I, K) mice. The views from the top are shown for the trabecular bone
in the secondary ossification center (F, G). (L-O) Trabecular bone volume (BV/TV), trabecular thickness (Tb.Th), trabecular number (Tb.N), and
trabecular bone mineral density (BMD) in the primary ossification center (L), secondary ossification center (M), and first lumber vertebrae (O); and
cortical area (CtAr/TtAr), cortical thickness (Ct.Th), and cortical bone mineral density (BMD) at mid-diaphysis of femurs (N). (P-W) Bone
histomorphometric analyses of cortical bone. Cross-sections from the mid-diaphyses of femurs in Runx2fl/fl (P, R, S) and Runx2fl/fl Cre mice (Q, T,
U) were analyzed. R and T show endosteum (end) and S and U show periosteum (per). (V, W) Mineral apposition rate (MAR), mineralizing surface
(MS/BS), and bone formation rate (BFR/BS) in the endosteum (V) and periosteum (W). BS, bone surface. Scale bars: 1 cm (A, B), 1 mm (D-K),
200 μm (P, Q) and 100 μm (R–U). The number of mice analyzed: Runx2fl/fl: 10, Runx2fl/fl/Cre: 9 in femurs and Runx2fl/fl: 6, Runx2fl/fl/Cre: 6 in
vertebrae. Data are the mean ± SD.
https://doi.org/10.1371/journal.pgen.1009169.g011
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femurs were used for bone histomorphometric analysis of cortical bone. The structural,
dynamic, and cellular parameters were calculated and expressed according to the standard
nomenclature [36].
Biomechanical testing
Femurs were isolated from females at 12 weeks of age, wrapped with Kimwipes dipped in
saline, and stored in a –30˚C freezer. The three-point bending test was performed in Kureha
Special Laboratory (Tokyo, Japan). After thawing the femurs, a load was applied vertically to
the midshaft with a constant rate of displacement of 2 mm/min until fracture using MZ-500D
(Maruto Testing Machine Co., Tokyo, Japan). A support span of 6 mm was used.
Statistical analysis
Values are shown as the mean ± SD. Statistical analyses of two groups were performed by the
Student’s t-test, and those of three groups were performed by analysis of variance and the
Tukey-Kramer post hoc test, A p-value of less than 0.05 was considered significant.
Fig 12. Bone histomorphometic analyses of vertebrae and tibiae in females at 6 and 12 weeks of age. (A-D) H-E and von Kossa staining
of lumbar vertebra of Runx2fl/fl (A, C) and Runx2fl/fl Cre (B, D) mice at 6 weeks (A, B) and 12 weeks (B, D) of age. (E and F) The trabecular
bone volume (bone volume/tissue volume, BV/TV), osteoblast surface (Ob.S/BS), osteoblast number (Ob.N/BS), osteoid surface (OS/BS),
osteoid thickness (O.Th), osteoclast surface (Oc.S/BS), osteoclast number (Oc.N/BS), eroded surface (ES/BS), mineral apposition rate
(MAR), mineralizing surface (MS/BS), bone formation rate (BFR/BS) at 6 weeks (E) and 12 weeks (F) of age. BS, bone surface. (G and H)
H-E and von Kossa staining of tibiae in Runx2fl/fl (G) and Runx2fl/fl Cre (H) mice at 12 weeks of age. (I) Bone histomorphometric analysis of
tibiae. Scale bars: 200 μm. The number of mice analyzed: Runx2fl/fl: 12, Runx2fl/fl Cre: 10 at 6 weeks of age; Runx2fl/fl: 7, Runx2fl/fl Cre: 6 at 12
weeks of age.
https://doi.org/10.1371/journal.pgen.1009169.g012
Fig 13. The three-point bending test. (A and B) Representative load-displacement curves for female Runx2fl/fl (A) and Runx2fl/flCre (B) mice at 12 weeks
of age. (C-G) Body weight (C), maximum load (D), displacement (E), stiffness (the slope of the linear part of the load) (F), and energy to failure (shaded
area under the curve) (G) in female Runx2fl/fl and Runx2fl/flCre mice. The number of mice analyzed: Runx2fl/fl: 6, Runx2fl/flCre: 6.
https://doi.org/10.1371/journal.pgen.1009169.g013
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Supporting information
S1 Fig. Generation of Runx2 flox mice. (A) Targeting vector and strategy for generating a
Runx2-flox mouse line. (B) Southern blot analyses of genomic DNA from wild-type and tar-
geted ES cells digested with XbaI or SacI using 5’ or 3’ probe shown in (A), respectively. (C)
PCR for genotyping to detect wild-type and floxed alleles in mice using F and R primers.
(PDF)
S2 Fig. Immunohistochemistry of Hmgb1. Immunohistochemistry using anti-Hmgb1 anti-
body was performed in femoral sections of Runx2fl/fl (A, C, E, G) and Runx2fl/fl Cre (B, D, F, H)
mice at E16.5. (A-D) Staining with DAPI. (E-H) Immunohistochemical analysis using anti-
Hmgb1 antibody. The boxed regions in A, B, E, F were magnified in C, D, G, H, respectively.
The dotted lines in E and F show the border between the growth plate and bone marrow. The
boxed cells in G and H were magnified in the windows. Scale bars: 50 μm (A, B, E, F), 20 μm
(C, D, G, H). (I) Cell area/total area, DyLight+ area, and intensity of DyLight in the boxed
regions without bone marrow area in E and H (hypertrophic and terminal hypertrophic chon-
drocyte layers) were compared between Runx2fl/fl and Runx2fl/fl Cre mice. The number of mice
analyzed: Runx2fl/fl: 4, Runx2fl/fl Cre: 4. Monoclonal rabbit anti-Hmgb1 antibody (Cell Signal-
ing, Danvers, MA) and goat anti-rabbit IgG H&L (DyLight 488) secondary antibody (Abcam,
Cambridge, UK) were used for the immunohistochemical analysis.
(PDF)
S3 Fig. β-galactosidase staining and immunohistochemistry of Col1a1. (A-C) Negative con-
trol for β-galactosidase staining using femoral sections from Runx2fl/fl mice at E15.5 (A),
Runx2fl/+ mice at E16.5 (B), and Runx2fl/+ LacZ mice at E17.5 (C). The boxed regions in A-C
and A’-C’ were magnified in A’-C’ and A”-C”, respectively. (D and E) Immunohistochemical
analysis of femoral sections using anti-Col1a1 antibody in Runx2fl/fl (D) and Runx2fl/flCre (E)
embryos at E15.5. Scale bars: 100 μm (A–C’, D, E), 50 μm (A”–C”). Two mice for each geno-
type were analyzed.
(PDF)
S4 Fig. Generation of 2.3 kb Co1a1 promoter tdTomato transgenic mice. (A) Construct of
the transgene. � Intron from SV40 containing splice donor and acceptor sites. �� polyadenyla-
tion signal from SV40. (B) Whole embryo at E14.5. (C-E) Frozen section of femur at P2.
The boxed regions in C were magnified in D and E. Pictures were taken using fluorescence
microscope (BZ-X710, KEYENCE, Osaka Japan). Scale bars: 1 mm (B), 500 μm (C), 100 μm
(D, E).
(PDF)
S5 Fig. β-galactosidase staining and micro-CT analysis. (A-C) β-galactosidase staining of
femoral sections from Runx2fl/fl (A), Runx2fl/+Cre LacZ (B), and Runx2fl/flCre LacZ (C) mice at
3 weeks of age. The boxed regions in A-C and A’-C’ were magnified in A’-C’ and A”-C”,
respectively. The secondary ossification center is shown. Arrows in B” indicate osteoblastic
cells. (D-G) Micro-CT images of femurs at 6 and 20 weeks of age. The trabecular bone
between the two lines with the distance of 0.36 mm in the secondary ossification center was
analyzed in Figs 10M and 11M. Scale bars: 200 μm (A-C), 20 μm (A’-C’), 10 μm (A”-C”), 0.5
mm (D-G).
(PDF)
S1 Table. Primer sequences for RT-PCR.
(PDF)
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